Novo Nordisk's Fill & Finish Expansion in Clayton, covering over 1.4 million square feet, represents a monumental leap in sustainable pharmaceutical manufacturing. This state-of-the-art facility includes essential structures like the Central Utility Building, Warehouse, Administration Building, and advanced production modules, all designed for future readiness. With a commitment to sustainability and aiming for LEED Gold certification, the project underscores Novo Nordisk's unwavering dedication to environmental responsibility. Our comprehensive engineering design and support services ensure the facility meets the highest standards, enhancing Novo Nordisk's capacity to meet the growing global demand for insulin and weight loss medications.
